1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. AI in CGT Manufacturing Market, by Component
7.1.1. Software
7.1.1.1. Market Revenue and Forecast
7.1.2. Services
7.1.2.1. Market Revenue and Forecast
8.1. AI in CGT Manufacturing Market, by Deployment Mode
8.1.1. Cloud-based
8.1.1.1. Market Revenue and Forecast
8.1.2. On-premises
8.1.2.1. Market Revenue and Forecast
8.1.3. Hybrid
8.1.3.1. Market Revenue and Forecast
9.1. AI in CGT Manufacturing Market, by Technology
9.1.1. Machine Learning (ML)
9.1.1.1. Market Revenue and Forecast
9.1.2. Deep Learning
9.1.2.1. Market Revenue and Forecast
9.1.3. Computer Vision
9.1.3.1. Market Revenue and Forecast
9.1.4. Natural Language Processing (NLP)
9.1.4.1. Market Revenue and Forecast
9.1.5. Reinforcement Learning
9.1.5.1. Market Revenue and Forecast
10.1. AI in CGT Manufacturing Market, by Manufacturing Stage
10.1.1. Upstream Processing
10.1.1.1. Market Revenue and Forecast
10.1.2. Cell Expansion
10.1.2.1. Market Revenue and Forecast
10.1.3. Gene Editing and Vector Production
10.1.3.1. Market Revenue and Forecast
10.1.4. Downstream Processing
10.1.4.1. Market Revenue and Forecast
10.1.5. Fill and Finish
10.1.5.1. Market Revenue and Forecast
10.1.6. Quality Control and Release Testing
10.1.6.1. Market Revenue and Forecast
11.1. AI in CGT Manufacturing Market, by Therapy Type
11.1.1. Cell Therapy
11.1.1.1. Market Revenue and Forecast
11.1.2. Gene Therapy
11.1.2.1. Market Revenue and Forecast
12.1. AI in CGT Manufacturing Market, by Application
12.1.1. Process Optimization
12.1.1.1. Market Revenue and Forecast
12.1.2. Predictive Maintenance
12.1.2.1. Market Revenue and Forecast
12.1.3. Quality Assurance and Quality Control
12.1.3.1. Market Revenue and Forecast
12.1.4. Process Monitoring
12.1.4.1. Market Revenue and Forecast
12.1.5. Batch Release Optimization
12.1.5.1. Market Revenue and Forecast
12.1.6. Supply Chain and Inventory Management
12.1.6.1. Market Revenue and Forecast
12.1.7. Regulatory Compliance
12.1.7.1. Market Revenue and Forecast
12.1.8. Digital Twin Simulation
12.1.8.1. Market Revenue and Forecast
13.1. AI in CGT Manufacturing Market, by End User
13.1.1. Biopharmaceutical Companies
13.1.1.1. Market Revenue and Forecast
13.1.2. Contract Development and Manufacturing Organizations (CDMOs)
13.1.2.1. Market Revenue and Forecast
13.1.3. Research Institutes
13.1.3.1. Market Revenue and Forecast
13.1.4. Academic Institutions
13.1.4.1. Market Revenue and Forecast
13.1.5. Hospitals and Cell Therapy Centers
13.1.5.1. Market Revenue and Forecast
14.1. AI in CGT Manufacturing Market, by Organization Size
14.1.1. Large Enterprises
14.1.1.1. Market Revenue and Forecast
14.1.2. Small and Medium-sized Enterprises (SMEs)
14.1.2.1. Market Revenue and Forecast
15.1. North America
15.1.1. Market Revenue and Forecast, by Component
15.1.2. Market Revenue and Forecast, by Deployment Mode
15.1.3. Market Revenue and Forecast, by Technology
15.1.4. Market Revenue and Forecast, by Manufacturing Stage
15.1.5. Market Revenue and Forecast, by Therapy Type
15.1.6. Market Revenue and Forecast, by Application
15.1.7. Market Revenue and Forecast, by End User
15.1.8. Market Revenue and Forecast, by Organization Size
15.1.9. U.S.
15.1.9.1. Market Revenue and Forecast, by Component
15.1.9.2. Market Revenue and Forecast, by Deployment Mode
15.1.9.3. Market Revenue and Forecast, by Technology
15.1.9.4. Market Revenue and Forecast, by Manufacturing Stage
15.1.9.5. Market Revenue and Forecast, by Therapy Type
15.1.9.6. Market Revenue and Forecast, by Application
15.1.9.7. Market Revenue and Forecast, by End User
15.1.9.8. Market Revenue and Forecast, by Organization Size
15.1.10. Rest of North America
15.1.10.1. Market Revenue and Forecast, by Component
15.1.10.2. Market Revenue and Forecast, by Deployment Mode
15.1.10.3. Market Revenue and Forecast, by Technology
15.1.10.4. Market Revenue and Forecast, by Manufacturing Stage
15.1.10.5. Market Revenue and Forecast, by Therapy Type
15.1.10.6. Market Revenue and Forecast, by Application
15.1.10.7. Market Revenue and Forecast, by End User
15.1.10.8. Market Revenue and Forecast, by Organization Size
15.2. Europe
15.2.1. Market Revenue and Forecast, by Component
15.2.2. Market Revenue and Forecast, by Deployment Mode
15.2.3. Market Revenue and Forecast, by Technology
15.2.4. Market Revenue and Forecast, by Manufacturing Stage
15.2.5. Market Revenue and Forecast, by Therapy Type
15.2.6. Market Revenue and Forecast, by Application
15.2.7. Market Revenue and Forecast, by End User
15.2.8. Market Revenue and Forecast, by Organization Size
15.2.9. UK
15.2.9.1. Market Revenue and Forecast, by Component
15.2.9.2. Market Revenue and Forecast, by Deployment Mode
15.2.9.3. Market Revenue and Forecast, by Technology
15.2.9.4. Market Revenue and Forecast, by Manufacturing Stage
15.2.9.5. Market Revenue and Forecast, by Therapy Type
15.2.9.6. Market Revenue and Forecast, by Application
15.2.9.7. Market Revenue and Forecast, by End User
15.2.9.8. Market Revenue and Forecast, by Organization Size
15.2.10. Germany
15.2.10.1. Market Revenue and Forecast, by Component
15.2.10.2. Market Revenue and Forecast, by Deployment Mode
15.2.10.3. Market Revenue and Forecast, by Technology
15.2.10.4. Market Revenue and Forecast, by Manufacturing Stage
15.2.10.5. Market Revenue and Forecast, by Therapy Type
15.2.10.6. Market Revenue and Forecast, by Application
15.2.10.7. Market Revenue and Forecast, by End User
15.2.10.8. Market Revenue and Forecast, by Organization Size
15.2.11. France
15.2.11.1. Market Revenue and Forecast, by Component
15.2.11.2. Market Revenue and Forecast, by Deployment Mode
15.2.11.3. Market Revenue and Forecast, by Technology
15.2.11.4. Market Revenue and Forecast, by Manufacturing Stage
15.2.11.5. Market Revenue and Forecast, by Therapy Type
15.2.11.6. Market Revenue and Forecast, by Application
15.2.11.7. Market Revenue and Forecast, by Organization Size
15.2.11.8. Market Revenue and Forecast, by End User
15.2.12. Rest of Europe
15.2.12.1. Market Revenue and Forecast, by Component
15.2.12.2. Market Revenue and Forecast, by Deployment Mode
15.2.12.3. Market Revenue and Forecast, by Technology
15.2.12.4. Market Revenue and Forecast, by Manufacturing Stage
15.2.12.5. Market Revenue and Forecast, by Therapy Type
15.2.12.6. Market Revenue and Forecast, by Application
15.2.12.7. Market Revenue and Forecast, by End User
15.2.12.8. Market Revenue and Forecast, by Organization Size
15.3. APAC
15.3.1. Market Revenue and Forecast, by Component
15.3.2. Market Revenue and Forecast, by Deployment Mode
15.3.3. Market Revenue and Forecast, by Technology
15.3.4. Market Revenue and Forecast, by Manufacturing Stage
15.3.5. Market Revenue and Forecast, by Therapy Type
15.3.6. Market Revenue and Forecast, by Application
15.3.7. Market Revenue and Forecast, by End User
15.3.8. Market Revenue and Forecast, by Organization Size
15.3.9. India
15.3.9.1. Market Revenue and Forecast, by Component
15.3.9.2. Market Revenue and Forecast, by Deployment Mode
15.3.9.3. Market Revenue and Forecast, by Technology
15.3.9.4. Market Revenue and Forecast, by Manufacturing Stage
15.3.9.5. Market Revenue and Forecast, by Therapy Type
15.3.9.6. Market Revenue and Forecast, by Application
15.3.9.7. Market Revenue and Forecast, by End User
15.3.9.8. Market Revenue and Forecast, by Organization Size
15.3.10. China
15.3.10.1. Market Revenue and Forecast, by Component
15.3.10.2. Market Revenue and Forecast, by Deployment Mode
15.3.10.3. Market Revenue and Forecast, by Technology
15.3.10.4. Market Revenue and Forecast, by Manufacturing Stage
15.3.10.5. Market Revenue and Forecast, by Therapy Type
15.3.10.6. Market Revenue and Forecast, by Application
15.3.10.7. Market Revenue and Forecast, by End User
15.3.10.8. Market Revenue and Forecast, by Organization Size
15.3.11. Japan
15.3.11.1. Market Revenue and Forecast, by Component
15.3.11.2. Market Revenue and Forecast, by Deployment Mode
15.3.11.3. Market Revenue and Forecast, by Technology
15.3.11.4. Market Revenue and Forecast, by Manufacturing Stage
15.3.11.5. Market Revenue and Forecast, by Therapy Type
15.3.11.6. Market Revenue and Forecast, by Application
15.3.11.7. Market Revenue and Forecast, by End User
15.3.11.8. Market Revenue and Forecast, by Organization Size
15.3.12. Rest of APAC
15.3.12.1. Market Revenue and Forecast, by Component
15.3.12.2. Market Revenue and Forecast, by Deployment Mode
15.3.12.3. Market Revenue and Forecast, by Technology
15.3.12.4. Market Revenue and Forecast, by Manufacturing Stage
15.3.12.5. Market Revenue and Forecast, by Therapy Type
15.3.12.6. Market Revenue and Forecast, by Application
15.3.12.7. Market Revenue and Forecast, by End User
15.3.12.8. Market Revenue and Forecast, by Organization Size
15.4. MEA
15.4.1. Market Revenue and Forecast, by Component
15.4.2. Market Revenue and Forecast, by Deployment Mode
15.4.3. Market Revenue and Forecast, by Technology
15.4.4. Market Revenue and Forecast, by Manufacturing Stage
15.4.5. Market Revenue and Forecast, by Therapy Type
15.4.6. Market Revenue and Forecast, by Application
15.4.7. Market Revenue and Forecast, by End User
15.4.8. Market Revenue and Forecast, by Organization Size
15.4.9. GCC
15.4.9.1. Market Revenue and Forecast, by Component
15.4.9.2. Market Revenue and Forecast, by Deployment Mode
15.4.9.3. Market Revenue and Forecast, by Technology
15.4.9.4. Market Revenue and Forecast, by Manufacturing Stage
15.4.9.5. Market Revenue and Forecast, by Therapy Type
15.4.9.6. Market Revenue and Forecast, by Application
15.4.9.7. Market Revenue and Forecast, by End User
15.4.9.8. Market Revenue and Forecast, by Organization Size
15.4.10. North Africa
15.4.10.1. Market Revenue and Forecast, by Component
15.4.10.2. Market Revenue and Forecast, by Deployment Mode
15.4.10.3. Market Revenue and Forecast, by Technology
15.4.10.4. Market Revenue and Forecast, by Manufacturing Stage
15.4.10.5. Market Revenue and Forecast, by Therapy Type
15.4.10.6. Market Revenue and Forecast, by Application
15.4.10.7. Market Revenue and Forecast, by End User
15.4.10.8. Market Revenue and Forecast, by Organization Size
15.4.11. South Africa
15.4.11.1. Market Revenue and Forecast, by Component
15.4.11.2. Market Revenue and Forecast, by Deployment Mode
15.4.11.3. Market Revenue and Forecast, by Technology
15.4.11.4. Market Revenue and Forecast, by Manufacturing Stage
15.4.11.5. Market Revenue and Forecast, by Therapy Type
15.4.11.6. Market Revenue and Forecast, by Application
15.4.11.7. Market Revenue and Forecast, by End User
15.4.11.8. Market Revenue and Forecast, by Organization Size
15.4.12. Rest of MEA
15.4.12.1. Market Revenue and Forecast, by Component
15.4.12.2. Market Revenue and Forecast, by Deployment Mode
15.4.12.3. Market Revenue and Forecast, by Technology
15.4.12.4. Market Revenue and Forecast, by Manufacturing Stage
15.4.12.5. Market Revenue and Forecast, by Therapy Type
15.4.12.6. Market Revenue and Forecast, by Application
15.4.12.7. Market Revenue and Forecast, by End User
15.4.12.8. Market Revenue and Forecast, by Organization Size
15.5. Latin America
15.5.1. Market Revenue and Forecast, by Component
15.5.2. Market Revenue and Forecast, by Deployment Mode
15.5.3. Market Revenue and Forecast, by Technology
15.5.4. Market Revenue and Forecast, by Manufacturing Stage
15.5.5. Market Revenue and Forecast, by Therapy Type
15.5.6. Market Revenue and Forecast, by Application
15.5.7. Market Revenue and Forecast, by End User
15.5.8. Market Revenue and Forecast, by Organization Size
15.5.9. Brazil
15.5.9.1. Market Revenue and Forecast, by Component
15.5.9.2. Market Revenue and Forecast, by Deployment Mode
15.5.9.3. Market Revenue and Forecast, by Technology
15.5.9.4. Market Revenue and Forecast, by Manufacturing Stage
15.5.9.5. Market Revenue and Forecast, by Therapy Type
15.5.9.6. Market Revenue and Forecast, by Application
15.5.9.7. Market Revenue and Forecast, by End User
15.5.9.8. Market Revenue and Forecast, by Organization Size
15.5.10. Rest of LATAM
15.5.10.1. Market Revenue and Forecast, by Component
15.5.10.2. Market Revenue and Forecast, by Deployment Mode
15.5.10.3. Market Revenue and Forecast, by Technology
15.5.10.4. Market Revenue and Forecast, by Manufacturing Stage
15.5.10.5. Market Revenue and Forecast, by Therapy Type
15.5.10.6. Market Revenue and Forecast, by Application
15.5.10.7. Market Revenue and Forecast, by End User
15.5.10.8. Market Revenue and Forecast, by Organization Size
16.1. Bluebird Bio Inc.
16.1.1. Company Overview
16.1.2. Product Offerings
16.1.3. Financial Performance
16.1.4. Recent Initiatives
16.2. Boehringer Ingelheim
16.2.1. Company Overview
16.2.2. Product Offerings
16.2.3. Financial Performance
16.2.4. Recent Initiatives
16.3. Catalent Inc.
16.3.1. Company Overview
16.3.2. Product Offerings
16.3.3. Financial Performance
16.3.4. Recent Initiatives
16.4. Cellular Therapeutics
16.4.1. Company Overview
16.4.2. Product Offerings
16.4.3. Financial Performance
16.4.4. Recent Initiatives
16.5. F. Hoffmann-La Roche Ltd
16.5.1. Company Overview
16.5.2. Product Offerings
16.5.3. Financial Performance
16.5.4. Recent Initiatives
16.6. Hitachi Chemical Co., Ltd.
16.6.1. Company Overview
16.6.2. Product Offerings
16.6.3. Financial Performance
16.6.4. Recent Initiatives
16.7. Lonza
16.7.1. Company Overview
16.7.2. Product Offerings
16.7.3. Financial Performance
16.7.4. Recent Initiatives
16.8. Merck KGaA
16.8.1. Company Overview
16.8.2. Product Offerings
16.8.3. Financial Performance
16.8.4. Recent Initiatives
16.9. Miltenyi Biotec
16.9.1. Company Overview
16.9.2. Product Offerings
16.9.3. Financial Performance
16.9.4. Recent Initiatives
16.10. Novartis AG
16.10.1. Company Overview
16.10.2. Product Offerings
16.10.3. Financial Performance
16.10.4. Recent Initiatives
16.7. Primary Research
16.7. Secondary Research
16.7. Assumptions
18.1. About Us
18.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
